In a nutshell This study looked at the link between a medication for erectile dysfunction (known as PDE5i) and the early screening of cardiovascular disease (CVD – heart and blood vessel disease). The study concluded that PDE5i use can help with the early detection for CVD. Some background Phosphodiesterase-5 inhibitors (PDE5is),...
Read More
Home »
Current treatment-Medications and/or supplements-Other medications or supplements
Current treatment-Medications and/or supplements-Other medications or supplements Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Men's Health
- Mental Health
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rare disease
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Array
(
[0] => WP_Term Object
(
[term_id] => 2223
[name] => Erectile dysfunction
[slug] => erectile-dysfunction
[term_group] => 0
[term_taxonomy_id] => 2224
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 132
[filter] => raw
[cat_ID] => 2223
[category_count] => 132
[category_description] =>
[cat_name] => Erectile dysfunction
[category_nicename] => erectile-dysfunction
[category_parent] => 0
)
)
Recent Posts
- Movember: More than facial hair–men’s health!
- Unlocking A Mystery: Mast Cells, Hypermobile Ehlers-Danlos Syndrome, and Genes
- Periodontal Disease: Keep your teeth clean for better health
- Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting
- Comparing the safety and effectiveness of hormonal therapy alone versus chemo-hormonal therapy before prostate surgery in men with locally advanced prostate cancer